Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.